What changed
Police in China and neighboring countries arrested 71 suspects in a cross-border investigation into etomidate trafficking. The case allegedly involved retired chemistry professor Wu and chemistry graduate Huang, with precursor production in China and final processing in Vietnam, Thailand and Cambodia.
Authorities seized about 73 kilograms of finished etomidate, five tonnes of active ingredients and laboratory equipment. Huang reportedly earned more than 5 million yuan, or about $750,000; the suspects are awaiting trial.
Why it matters
The operation shows how a drug supply chain can be divided across borders. Chinese facilities allegedly produced precursor chemicals, while laboratories elsewhere handled the final processing. That structure meant police in several countries had to raid simultaneously.
The investigation began in Shandong in 2024 after a pharmaceutical technology company bought unusually large quantities of six chemicals used to make etomidate. China had placed the drug under strict state control in 2023 because high doses can cause serious harm or death.
Wu allegedly designed the manufacturing process and used professional contacts to establish hidden laboratories in factories across five Chinese cities under the cover of medical research. Huang, who had worked at the pharmaceutical company for only three months, reportedly used his chemistry training and e-cigarette business experience to help organize the operation.
The arrests may disrupt this network, but whether they reduce the drug’s wider availability will depend on what investigators and courts establish about the supply chain. For now, the clearest fact is its scale: the alleged operation connected technical expertise, industrial chemical purchasing and production spread across four countries.
Comments
No comments yet.